Intravitreal bevacizumab compared with photodynamic therapy with verteporfin for group 2a parafoveal retinal telangiectasis

Canadian Journal of Ophthalmology

Volumn 43, Issue 4, 2008, Pages 489-490

  Windisch, Roman ^a   Kozousek, Vladimir ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; VERTEPORFIN;

ADULT; CASE REPORT; DISEASE COURSE; HUMAN; LASER COAGULATION; LETTER; OPTICAL COHERENCE TOMOGRAPHY; PARAFOVEAL RETINA TELANGIECTASIA; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA EDEMA; TELANGIECTASIA; VISUAL ACUITY;

EID: 49949085246     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/I08-069     Document Type: Letter

References (7)

1. Gass JD, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasia. Update on classification and follow-up study. Ophthalmology 1993;100:1536-46.
2. Yannuzzi LA, Bardal AM, Freund KB, Chen KJ, Eandi CM, Blodi B. Idiopathic macular telangiectasia. Arch Ophthalmol 2006; 124:450-60.
3. Potter MJ, Szabo SM, Sarraf D, Michels R, Schmidt-Erfurth U. Photodynamic therapy for subretinal neovascularization in type 2A idiopathic juxtafoveolar telangiectasis. Can J Ophthalmol 2006;41:34-7.
4. Maia Júnior OO, Bonanomi MT, Takahashi WY, Nascimento VP, Takahashi BS. Intravitreal bevacizumab for foveal detachment in idiopathic perifoveal telangiectasia. Am J Ophthalmol 2007; 144:296-9.
5. Adamis AP, Shima DT. The role of vascular endothelial growth factor in ocular health and disease. Retina 2005;25:111-8.
6. Charbel Issa P, Holz FG, Scholl HP. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Ophthalmology 2007;114:1736-42.
7. Schulze S, Mennel S. Treatment of idiopathic juxtafoveolar retinal telangiectasis with bevacizumab (avastin) [in German]. Klin Monatsbl Augenheilkd 2007;224:787-90.